33 research outputs found
THE SMALL FATAL CHOROIDAL MELANOMA STUDY A Survey by the European Ophthalmic Oncology Group
PURPOSE: To determine the size at which choroidal melanomas can metastasize and to report the characteristics of small fatal choroidal melanomas (SFCM). DESIGN: Retrospective case series. METHODS: Ten ocular oncology services submitted 45 patients with a choroidal melanoma 3 mm or less in thickness and 9 mm or less in largest basal diameter (LBD), when treated, who developed metastases. RESULTS: Median tumor thickness was 2.4 mm (range, 1.0-3.0 mm) and LBD 7.3 mm (range, 3.0-9.0 mm). Of 14 (31%) tumors that were first observed, 12 grew a median of 0.5 mm (range, 0.1-1.2 mm) in thickness and 1.0 mm (range, 0-3.0 mm) in LBD within a median of 7 months; 3 were initially smaller than 3 mm in LBD. Number of risk factors for growth and metastasis was 0 for 4% of the tumors; 60% were over 2 mm in thickness, 63% had subretinal fluid, 84% caused symptoms, 57% had orange pigment, and 92% were within 3 mm of the disc. Local recurrence occurred in 8 of 31 eyes (26%) treated conservatively. Median metastasis-free survival was 4.5 years (range, 0.8-15.7 years). Kaplan-Meier estimate of metastasis developing was 15% (95% confidence interval [CI], 7-26), 51% (95% CI, 36-64) and 85% (95% CI, 71-92) by 2, 5, and 10 years, respectively. By the time of analysis, 37 patients had died of metastasis after a median of 7 months. CONCLUSIONS: Choroidal melanomas less than 3.0 mm in LBD are highly unlikely to metastasize. Risk factors of an SFCM are similar to those for all choroidal melanomas of similar size. (C) 2019 The Author(s). Published by Elsevier Inc.Peer reviewe
Résultats de 16 ans de traitement des mélanomes uvéaux postérieurs par protonthérapie et de collaboration entre le CHU de Nice et le Centre Antoine Lacassagne
NICE-BU MĂ©decine Odontologie (060882102) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Traitement par protonthérapie des mélanomes choroïdiens de grande taille
NICE-BU MĂ©decine Odontologie (060882102) / SudocSudocFranceF
Traitements actuels des hémangiomes circonscrits de la choroïde
NICE-BU MĂ©decine Odontologie (060882102) / SudocSudocFranceF
Récidives locales des mélanomes uveaux traités par protonthérapie
NICE-BU MĂ©decine Odontologie (060882102) / SudocSudocFranceF
Choroidal Metastasis From Melanoma Treated by Cyberknife Irradiation
International audienceA 36-year-old woman presented with visual deterioration and headache. Ophthalmologic examination results showed a 5-mm-thick choroidal mass in her right eye. Head and chest computed tomography scans showed brain and lung metastases. A resection of her lung nodule revealed metastatic BRAF V600âmutated melanoma. The patient underwent systemic targeted therapy followed by 6 sessions of Gamma Knife (Elekta) irradiation for her brain metastases. Ocular Cyberknife (Accuray) stereotactic radiotherapy was performed with a macular- and optic nerveâsparing approach. Despite disease progression in the brain, the abnormal thickness resolved in her eye and her visual acuity increased from 20/200 OD to 16/20 OD at 3 months
Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres
International audienc